Efficacy and safety of new oral anticoagulants compared with warfarin in cardioembolic prophylaxis of patients with non valvular atrial fibrillation. More lights than shadows

Efficacy and safety of new oral anticoagulants compared with warfarin in cardioembolic prophylaxis of patients with non valvular atrial fibrillation. More lights than shadows

<p>Introduction<br />The prophylaxis of thromboembolic events represents a key point in the modern management of patients with non valvular atrial fibrillation (AF), both paroxysmal and persistent/permanent. Up to now, vitamin K antagonist (VKA) drugs are the first choice in thromboembol...

Full description

Bibliographic Details
Main Authors: Luca Masotti, Mario Di Napoli, Walter Ageno, Davide Imberti, Daniel Godoy, Grazia Panigada, Niccolò Napoli, Giancarlo Landini, Roberto Cappelli, Ido Iori, Domenico Prisco, Giancarlo Agnelli
Format: Article
Language:English
Published: PAGEPress Publications 2012-10-01
Series:Italian Journal of Medicine
Subjects:
Atrial fibrillation
Stroke
Dabigatran
Rivaroxaban
Apixaban
Online Access:http://www.italjmed.org/index.php/ijm/article/view/10

Internet

http://www.italjmed.org/index.php/ijm/article/view/10

Similar Items